Abstract | OBJECTIVE: METHODS: RESULTS: Twenty-seven patients were entered on this study. All patients were evaluable for toxicity and 26 were evaluable for response. A median of 2 courses of therapy (range 1-10) was given. No grade 4 toxicities were noted. Three patients (11.1%) had partial responses. CONCLUSION:
|
Authors | Peter G Rose, John A Blessing, Shashikant Lele, Ovadia Abulafia |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 102
Issue 2
Pg. 210-3
(Aug 2006)
ISSN: 0090-8258 [Print] United States |
PMID | 16478630
(Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antibiotics, Antineoplastic
- liposomal doxorubicin
- Polyethylene Glycols
- Doxorubicin
|
Topics |
- Adult
- Aged
- Antibiotics, Antineoplastic
(adverse effects, therapeutic use)
- Carcinoma, Squamous Cell
(drug therapy)
- Doxorubicin
(adverse effects, analogs & derivatives, therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Polyethylene Glycols
(adverse effects, therapeutic use)
- Uterine Cervical Neoplasms
(drug therapy)
|